-->
Catégorie: Trader 
membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
06-05-24 11:01
17
+3.8%Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 03/05/24 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.30 | 6.30 | -0.27% | -3 | 
|
0 |
| 29/04/24 | MANITOU GROUP | Achat | 1 000 E | 22.50 | 23.95 | 6.07% | 61 |
|
0 |
| 29/04/24 | MANITOU GROUP | Achat | 1 000 E | 22.85 | 23.95 | 4.45% | 45 |
|
0 |
| 29/04/24 | MANITOU GROUP | Achat | 1 000 E | 22.85 | 23.95 | 4.45% | 45 |
|
0 |
| 24/04/24 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 5.75 | 6.30 | 9.08% | 91 |
|
0 |
| 18/04/24 | LVMH | Achat | 1 000 E | 801.00 | 781.30 | -3.08% | -31 |
|
0 |
| 08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 8.36 | -19.64% | -79 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 6.30 | 37.62% | 150 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 4.57 | 6.30 | 36.64% | 366 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 2.93 | -8.91% | -36 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 2.93 | -8.91% | -36 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 2.93 | -8.91% | -36 |
|
0 |
| 18/03/24 | ESKER | Achat | 400 E | 180.10 | 180.90 | 0.24% | 1 |
|
1 |
| 04/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 5.20 | 6.30 | 19.46% | 195 |
|
0 |
| 26/02/24 | ADOCIA | Achat | 1 000 E | 10.72 | 8.36 | -23.82% | -238 |
|
0 |
| 30/01/24 | ADOCIA | Achat | 500 E | 11.14 | 8.36 | -25.13% | -126 |
|
0 |
| 11/01/24 | ARCURE | Achat | 400 E | 2.89 | 6.70 | 131.50% | 526 |
|
0 |
| 09/01/24 | ARCURE | Achat | 400 E | 2.70 | 6.70 | 147.80% | 591 |
|
0 |
| 09/01/24 | ARCURE | Achat | 400 E | 2.70 | 6.70 | 147.80% | 591 |
|
0 |
| 20/12/23 | LVMH | Achat | 500 E | 749.10 | 781.30 | 4.09% | 20 |
|
0 |
| 18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 2.23 | -4.90% | -20 |
|
0 |
| 16/11/23 | ADOCIA | Achat | 400 E | 9.58 | 8.36 | -12.92% | -52 |
|
0 |
| 10/11/23 | LVMH | Achat | 400 E | 696.00 | 781.30 | 12.04% | 48 |
|
0 |
| 08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 4.46 | -31.13% | -125 |
|
0 |
| 19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.69 | -29.46% | -147 |
|
0 |
| 18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.69 | -30.34% | -121 |
|
0 |
| 14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 4.46 | 3.04% | 12 |
|
0 |
| 13/06/23 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 3.52 | 6.30 | 78.70% | 394 |
|
0 |
| 13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 2.23 | -30.48% | -122 |
|
0 |
| 09/06/23 | VALBIOTIS | Achat | 400 E | 4.58 | 4.46 | -2.82% | -11 |
|
1 |
| 13/01/23 | ESKER | Achat | 400 E | 164.10 | 180.90 | 10.03% | 40 |
|
1 |
| 21/12/22 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 6.35 | 6.30 | -0.99% | -4 |
|
1 |
| 25/03/22 | ESKER | Achat | 400 E | 161.40 | 180.90 | 11.87% | 47 |
|
5 |
| 16/02/22 | ESKER | Achat | 400 E | 215.00 | 180.90 | -16.04% | -64 |
|
5 |
| 11/01/22 | ESKER | Achat | 400 E | 299.50 | 180.90 | -39.76% | -159 |
|
4 |
| 01/12/21 | ESKER | Achat | 400 E | 337.00 | 180.90 | -46.47% | -186 |
|
5 |
| 23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 6.30 | -43.70% | -175 |
|
7 |
| 23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 2.23 | -63.88% | -256 |
|
7 |
| 21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 2.23 | -62.47% | -250 |
|
7 |
| 20/09/21 | ESKER | Achat | 400 E | 279.50 | 180.90 | -35.44% | -142 |
|
7 |
| 15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 4.46 | -43.84% | -175 |
|
7 |
| 14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 4.46 | -45.70% | -183 |
|
5 |
| 06/04/21 | ESKER | Achat | 400 E | 202.00 | 180.90 | -10.64% | -43 |
|
7 |
| 31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.69 | -86.03% | -344 |
|
7 |
| 31/03/21 | ESKER | Achat | 400 E | 197.80 | 180.90 | -8.74% | -35 |
|
6 |
| 24/03/21 | ADVICENNE | Achat | 300 E | 12.70 | 1.69 | -86.81% | -260 |
|
3 |
| 16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 4.46 | -43.27% | -173 |
|
7 |
| 09/03/21 | ESKER | Achat | 400 E | 190.20 | 180.90 | -5.08% | -20 |
|
7 |
| 10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 4.46 | -41.16% | -123 |
|
7 |
| 04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 4.46 | -36.27% | -109 |
|
4 |
| Enregistrements 1 à 50 sur 74 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 25/10/17 | RIBER | Achat | 300 E | 3.06 | 3.55 | 15.80% | 47 |  |
4 |
| 25/10/17 | RIBER | Achat | 300 E | 3.10 | 3.54 | 13.98% | 42 | |
4 |
| 23/10/17 | RIBER | Achat | 600 E | 2.95 | 3.20 | 8.27% | 50 | |
6 |
| 19/10/17 | RIBER | Achat | 600 E | 2.55 | 2.65 | 3.72% | 22 | |
7 |
| 16/10/17 | BASTIDE LE CONFORT | Achat | 2 000 E | 43.75 | 44.90 | 2.43% | 49 | |
14 |
| Enregistrements 1001 à 1005 sur 1005 | |||||||||
-->
